The vast majority of people with a penicillin allergy label are, in fact, not allergic, leading to significant healthcare implications. Experts say it is now time for a national “de-labelling” drive to help conserve vital antibiotics.
The COVID-19 pandemic has forced radical changes to how the 2020 class of preregistration trainees will transition into their careers.
The under-representation of women in clinical trials is slowly being addressed, but we cannot move towards truly personalised healthcare unless we have an equal balance of the sexes in all new medicine trials.
Footfall in emergency departments across the world has decreased during the COVID-19 pandemic, and experts worry that patients with symptoms are staying at home for fear of burdening their healthcare systems. But preventing serious cardiovascular events is still as important as ever, says cardiology consultant pharmacist Rani Khatib.
The pharmacy minister on the response to the COVID-19 pandemic, mental health support for pharmacists and what may be the enduring legacy for the sector.
Insomnia disorder: diagnosis and preventionSubscription
Insomnia can have a profound impact on a patient; understanding its causes and how it can be prevented can have significant implications on their wellbeing.
Alcohol consumption has increased during the COVID-19 pandemic. Pharmacists can provide patients with support and information to enable them to make informed choices about their intake.
Pharmacists should be aware that the law around organ donation changed in England in May 2020 and will change in Scotland from March 2021, and should understand the implications this has on practice and for patients.
A review of several of the treatments for COVID-19 currently being trialled.
Pharmacy professionals share their advice with the new cohort of preregistration pharmacists about to start their training during the COVID-19 pandemic.
With COVID-19 becoming the number one priority for researchers around the globe, Parham Hashemi describes his role in overseeing the new trials being launched during the pandemic.
False penicillin allergies are placing patients at risk of resistant infections and are a threat to antimicrobial stewardship; we must safely de-label patients to avoid these costs to public health.
The high proportion of people from black, Asian and minority ethnic groups dying from COVID-19 has brought health inequalities between ethnic groups to the fore, but this should have been looked into long before the pandemic began.
Attending a pharmacist-led medicines optimisation clinic after hospital discharge could help to reduce patient readmissions, visits to A&E and unplanned GP consultations, a study published in the International Journal of Clinical Pharmacy has found.
Low-dose dexamethasone, a “widely available, safe and well-known drug”, is the first medicine to be shown to result in a “significant reduction in mortality” in those with COVID-19 requiring oxygen or ventilation, researchers have said.
Development of a pharmacy degree apprenticeship has been put on hold because of the COVID-19 pandemic, the body responsible for building healthcare workforce capacity has said.
The government’s scientific panel set up to advise on the COVID-19 pandemic has recommended the government considers vaccinating “the entire UK population” against flu during the 2020/2021 season.
Plans for hospitals to digitally refer discharged patients to community pharmacies across England have been put on hold as a result of the COVID-19 pandemic.
Navin Shantilal Talati, a pharmacist and founder of Talati Chemist in Dagenham, has died from COVID-19, The Pharmaceutical Journal has learned.